Target intelligence / Profile preview

Neuronal nicotinic acetylcholine receptor beta 2-containing subtypes (beta2-nAChR)

Target
beta2-nAChR
Molecular classification
Ion channel, Ligand-gated ion channel, Nicotinic acetylcholine receptor, Receptor
01

Overview

Other beta 2-containing neuronal nicotinic acetylcholine receptors (nAChRs) represent a diverse group of pentameric ligand-gated ion channels that incorporate the beta 2 subunit (encoded by the CHRNB2 gene) in combination with alpha subunits other than alpha 4, such as alpha 2, alpha 3, or alpha 6 (Source: UniProt P17677). These receptors are widely distributed throughout the central and peripheral nervous systems, where they modulate the release of various neurotransmitters, including dopamine, GABA, and glutamate. While the alpha 4 beta 2 subtype is the most prevalent high-affinity nicotine-binding receptor in the brain, these 'other' beta 2-containing receptors play specialized roles in circuits related to reward, motor control, and autonomic function (Source: PubMed PMC2629101). For instance, alpha 6 beta 2-containing receptors are highly localized in dopaminergic pathways of the striatum and are significant targets for Parkinson's disease and addiction research. Mutations in the CHRNB2 gene are specifically linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), highlighting the receptor's role in maintaining excitatory-inhibitory balance in the cerebral cortex (Source: NIH Genetics Home Reference). Pharmacological targeting of these receptors aims to treat cognitive deficits and substance use disorders, though achieving subtype selectivity remains a major challenge to avoid off-target autonomic effects associated with alpha 3-containing variants found in ganglia.

Other names
CHRNB2-containing nicotinic receptorsNon-alpha4beta2 nicotinic receptorsalpha3beta2 nAChRalpha6beta2 nAChRalpha2beta2 nAChRHeteromeric neuronal nicotinic receptors
02

Mechanism of action

Ligand-gated ion channel activation or modulation, leading to the influx of cations such as sodium (Na+) and calcium (Ca2+), which results in neuronal depolarization and the subsequent release of neurotransmitters like dopamine and glutamate (Source: IUPHAR/BPS Guide to Pharmacology).

03

Biological functions

NeurotransmissionSynaptic plasticityDopamine release modulationCation transportCholinergic signaling
04

Disease associations

Nicotine dependenceParkinson's diseaseAutosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)Cognitive impairmentAlzheimer's disease
05

Safety considerations

Autonomic nervous system toxicity (particularly with alpha3-containing subtypes)Gastrointestinal distress (nausea/vomiting)Cardiovascular stimulation (tachycardia, hypertension)Sleep disturbances and vivid dreams
06

Interacting drugs

Nicotine

7 more in the full profile.

07

Biomarkers

CHRNB2 gene mutations[18F]nifene (PET imaging ligand)[123I]5-IA-85380 (SPECT imaging ligand)

Beyond the preview

Go deeper on Neuronal nicotinic acetylcholine receptor beta 2-containing subtypes (beta2-nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal nicotinic acetylcholine receptor beta 2-containing subtypes (beta2-nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call